Cargando…

Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery

A transdermal drug delivery system (TDDS) is a method that provides drug adsorption via the skin. TDDS could replace conventional oral administration and blood administration because it is easily accessible. However, it is still difficult to design efficient TDDS due to the high barrier property of...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchida, Noriyuki, Yanagi, Masayoshi, Hamada, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911274/
https://www.ncbi.nlm.nih.gov/pubmed/33525364
http://dx.doi.org/10.3390/nano11020335
_version_ 1783656302991376384
author Uchida, Noriyuki
Yanagi, Masayoshi
Hamada, Hiroki
author_facet Uchida, Noriyuki
Yanagi, Masayoshi
Hamada, Hiroki
author_sort Uchida, Noriyuki
collection PubMed
description A transdermal drug delivery system (TDDS) is a method that provides drug adsorption via the skin. TDDS could replace conventional oral administration and blood administration because it is easily accessible. However, it is still difficult to design efficient TDDS due to the high barrier property of skin covered with stratum corneum, which inhibits the permeation of drug molecules. Thus far, TDDS methods by applying physical stimuli such as microneedles and chemical stimuli such as surfactants have been actively developed. However, it has been hard to avoid inflammation at the administration site because these methods partially destroy the skin tissue. On the other hand, TDDS with nanocarriers minimizing damage to the skin tissues has emerged together with the development of nanotechnology in recent years. This review focuses on current trends in TDDS.
format Online
Article
Text
id pubmed-7911274
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79112742021-02-28 Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery Uchida, Noriyuki Yanagi, Masayoshi Hamada, Hiroki Nanomaterials (Basel) Review A transdermal drug delivery system (TDDS) is a method that provides drug adsorption via the skin. TDDS could replace conventional oral administration and blood administration because it is easily accessible. However, it is still difficult to design efficient TDDS due to the high barrier property of skin covered with stratum corneum, which inhibits the permeation of drug molecules. Thus far, TDDS methods by applying physical stimuli such as microneedles and chemical stimuli such as surfactants have been actively developed. However, it has been hard to avoid inflammation at the administration site because these methods partially destroy the skin tissue. On the other hand, TDDS with nanocarriers minimizing damage to the skin tissues has emerged together with the development of nanotechnology in recent years. This review focuses on current trends in TDDS. MDPI 2021-01-28 /pmc/articles/PMC7911274/ /pubmed/33525364 http://dx.doi.org/10.3390/nano11020335 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Uchida, Noriyuki
Yanagi, Masayoshi
Hamada, Hiroki
Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery
title Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery
title_full Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery
title_fullStr Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery
title_full_unstemmed Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery
title_short Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery
title_sort physical enhancement? nanocarrier? current progress in transdermal drug delivery
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911274/
https://www.ncbi.nlm.nih.gov/pubmed/33525364
http://dx.doi.org/10.3390/nano11020335
work_keys_str_mv AT uchidanoriyuki physicalenhancementnanocarriercurrentprogressintransdermaldrugdelivery
AT yanagimasayoshi physicalenhancementnanocarriercurrentprogressintransdermaldrugdelivery
AT hamadahiroki physicalenhancementnanocarriercurrentprogressintransdermaldrugdelivery